Lanthanum Carbonate Tablet, Chewable
Product Images NDC 69097-935

4 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lanthanum Carbonate (NDC 69097-935). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lanthanum 01)

Figure 1 (Lanthanum 01)
A line graph depicting the difference in phosphorus reduction (mg/dL) versus placebo by dose of lanthanum carbonate (225 mg, 675 mg, 1350 mg, 2250 mg). The graph shows a trend of increasing phosphorus reduction with higher doses of lanthanum carbonate, with error bars indicating variability at each dose level.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Package)

Principal Display Panel (500 mg Tablet Bottle Package)
This packaging label is for Lanthanum Carbonate chewable tablets, 500 mg strength, marketed by Cipla USA Inc. The label states that each package contains 2 bottles with 45 chewable tablets each. It includes instructions for patients to not swallow tablets whole and to chew or crush completely before swallowing. The label also provides manufacturer and storage information, along with a barcode and Rx only designation.*
FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Package)

Principal Display Panel (750 mg Tablet Bottle Package)
Lanthanum Carbonate 750 mg chewable tablets packaging label from Cipla USA Inc. The carton is labeled for a 6-bottle supply, each bottle containing 15 chewable tablets. The label includes directions to not swallow tablets whole but to chew or crush completely before swallowing, with or immediately after meals. It lists the labeler and manufacturer addresses and states each package is designed as one month's therapy.*
FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Package)

Principal Display Panel (1000 mg Tablet Bottle Package)
The packaging label for Lanthanum Carbonate chewable tablets 1000 mg by Cipla USA Inc. The carton contains 9 bottles, each with 10 chewable tablets. The label includes directions to not swallow tablets whole and to chew or crush completely before swallowing. It also provides patient and pharmacist instructions and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.